Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 79 results for "Byetta"

Byetta improves liver metabolism in patients with NAFLD

BARCELONA — Byetta, a glucagon-like peptide-1 agonist approved for the treatment of type 2 diabetes mellitus, improved hepatic insulin resistance and adipose tissue in men with nonalcoholic fatty liver disease, according to a poster presentation ... Healio, 1 month ago
Yahoo! Singapore

US FDA panel recommends approval of Novo Nordisk diabetes drug

A US advisory panel on Tuesday recommended approval of a new diabetes drug made by Novo Nordisk A/S that combines two of its existing treatments in a fixed-dose combination created to be both effective and convenient. Although the FDA is not bound ...
 Equilibrio Informativo18 hours ago U.S. panel backs approval of Sanofi combination diabetes drug  Yahoo! Singapore3 days ago US panel backs approval of Sanofi combination diabetes drug  The Malaysian Times3 days ago UPDATE 2-U.S. panel backs approval of Sanofi combination diabetes drug  Reuters UK3 days ago

Sanofi's Diabetes and Cardiovascular Franchise Performance

What Drives Sanofi's Valuation? ( Continued from Prior Part ) Diabetes and Cardiovascular franchise revenue Sanofi (SNY) has reorganized its Diabetes and Cardiovascular franchise, making it one of the largest revenue contributors for Sanofi's ...
 Yahoo! Finance UK and Ireland4 days ago
Yahoo! Singapore

FDA staff question usefulness of Sanofi diabetes drugs

By Toni Clarke (Reuters) - A preliminary review by the U.S. Food and Drug Administration questioned the usefulness of a combination diabetes drug made by Sanofi SA's and said it was unclear whether one component, lixisenatide, contributed to its ...
 Yahoo! Singapore5 days ago UPDATE 1-FDA staff question utility of Sanofi diabetes drugs  London South East5 days ago FDA staff question utility of Sanofi diabetes drugs  Pharma Live5 days ago UPDATE 2-FDA staff question usefulness of Sanofi diabetes drugs  Reuters UK5 days ago

Global Diabetes Injection Pens Market Report Provides a Comprehensive View & Included a Detailed of Competitive Scenario and Product Portfolio of Key Vendors.

The report provides a comprehensive view on the diabetes injection pens; we have included a detailed competitive scenario and product portfolio of key vendors. The report segments the diabetes injection pens market on the basis of type of devices, ...
 Digital Journal5 days ago Global Antidiabetics Market, Size and Forecasts in Terms of Revenue (USD Million) for the Period 2016 to 2020.  Digital Journal1 week ago Non-alcoholic Steatohepatitis Therapeutics Market 2016 to 2020  Before It's News2 weeks ago Diabetes Injection Pens Market 2016-2020 Industry Examined by Syndicate Market Research  Digital Journal3 weeks ago

Intarcia to Submit its GLP-1 Mini-Pump Implant Device for Type 2 Diabetes to FDA Later this Year

Intarcia recently released reassuring results from a heart safety study of ITCA 650 a small GLP-1 mini-pump device to treat type 2 diabetes showing it meets the FDA's heart safety pre-approval requirements. The device continuously releases ...
 diaTribe5 days ago Promising revolution, Intarcia's diabetes device poised for filing  pharmaphorum2 weeks ago

Peptide Therapeutics in Metabolic Disorders, 2016 - 2025

Comments NEW YORK, March 3, 2016 /PRNewswire/ -- INTRODUCTION Peptide therapeutics, due to their numerous advantages such as high selectivity, stability, efficacy, safety, bioavailability and tolerability offer a number of benefits over other ...
 AndhraNews.net6 days ago

ORMP: Oramed Announces Positive Top-Line Data from Phase IIb ORMD-0801 Study

By Grant Zeng, CFA NASDAQ:ORMP On May 18, 2016, Oramed Pharmaceuticals Inc. (ORMP) announced positive top-line data from its Phase IIb study of ORMD-0801 in patients with type 2 diabetes. The study achieved its primary objective: a significant ...
 Yahoo! Finance1 week ago

Digital healthcare round-up: drones, organs-on-chips, diabetes implants and more

A round-up of this week's top digital healthcare news. Marco Ricci reports. Marco Ricci Release the drones The concept of drone delivery felt like a pipedream when a certain online shopping giant demonstrated its prototype last year. ...
 pharmaphorum2 weeks ago

Antares Pharma's (ATRS) CEO Bob Apple on Q1 2016 Results - Earnings Call Transcript

Antares Pharma Inc. (NASDAQ: ATRS ) Q1 2016 Earnings Conference Call May 9, 2016 08:30 ET Executives Jack Howarth - Vice President, Corporate Affairs Bob Apple - President and Chief Executive Officer Jim Fickenscher - Senior Vice ...
 Seeking Alpha2 weeks ago Insider Buying At Antares Pharma  Seeking Alpha2 months ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Get updated on latest news & your favorite topics right in your inbox!
More     Less